Maternal-foetal Transmission of SARS-Cov-2

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

May 4, 2021

Study Completion Date

May 4, 2021

Conditions
Maternal Fetal Infection TransmissionCOVID-19SARS-CoV 2
Interventions
DIAGNOSTIC_TEST

Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta

"During labor and delivery~1. Sample of amniotic fluid~2. 2 samples of blood cord after the birth of the new born~3. 2 samples of placenta~These samples will be tested with A RT-PCR COVID-19 test and / or serology's A sample of blood cord and placenta will be frozen at -80 degree C and studied for PCR and viral proteome, cytokines , D-dimers and others inflammatory markers in the PRIMMO Laboratory (Prof. TOUMI and LESPESSAILLES) and after in the Centre of molecular biophysics of CNRS of Orleans (Prof. PICHON)"

Trial Locations (1)

Unknown

CHR Orléans, Orléans

All Listed Sponsors
collaborator

Centre de Biophysique Moléculaire - Pr Chantal Pichon

UNKNOWN

collaborator

Professeur TOUMI Hechmi

UNKNOWN

lead

Centre Hospitalier Régional d'Orléans

OTHER

NCT04395924 - Maternal-foetal Transmission of SARS-Cov-2 | Biotech Hunter | Biotech Hunter